Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms

Biochemical Pharmacology

Volumn 75, Issue 9, 2008, Pages 1817-1826

  Frick, Luciana Romina ^a   Palumbo, María Laura ^a   Zappia, María Paula ^a   Brocco, Marcela Adriana ^a   Cremaschi, Graciela Alicia ^a   Genaro, Ana María ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Cellular immunity; Fluoxetine; Serotonin; T lymphoma; T cell; Tumor progression

Indexed keywords

FLUOXETINE; GAMMA INTERFERON; MITOGENIC AGENT; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CANCER INHIBITION; CANCER MODEL; CANCER SURVIVAL; CD4 CD8 RATIO; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; IMMUNOMODULATION; LONG TERM CARE; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; SURVIVAL TIME; T LYMPHOCYTE;

ANIMALS; CD4-CD8 RATIO; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; FEMALE; FLUOXETINE; IMMUNITY, CELLULAR; LYMPH NODES; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; T-LYMPHOCYTES;

EID: 41949139966     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.01.015     Document Type: Article

References (44)

1. Stafford R.S., MacDonald E.A., and Finkelstein S.N. National Patterns of Medication Treatment for Depression, 1987-2001. Prim Care Companion J Clin Psychiatry 3 (2001) 232-235
2. Anderson G.M., Bennett A.J., Weld K.P., Pushkas J.G., Ocame D.M., and Higley J.D. Serotonin in cisternal cerebrospinal fluid of rhesus monkeys: basal levels and effects of sertraline administration. Psychopharmacology (Berl) 161 (2002) 95-99
3. Pellegrino T.C., and Bayer B.M. Modulation of immune cell function following fluoxetine administration in rats. Pharmacol Biochem Behav 59 (1998) 151-157
4. Pellegrino T.C., and Bayer B.M. Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity. Brain Behav Immun 16 (2002) 87-103
5. Nunez M.J., Balboa J., Rodrigo E., Brenlla J., Gonzalez-Peteiro M., and Freire-Garabal M. Effects of fluoxetine on cellular immune response in stressed mice. Neurosci Lett 396 (2006) 247-251
6. Edgar V.A., Cremaschi G.A., Sterin-Borda L., and Genaro A.M. Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine. Brain Behav Immun 16 (2002) 333-350
7. Edgar V.A., Genaro A.M., Cremaschi G., and Sterin-Borda L. Fluoxetine action on murine T-lymphocyte proliferation: participation of PKC activation and calcium mobilisation. Cell Signal 10 (1998) 721-726
8. Steingart A.B., and Cotterchio M. Do antidepressants cause, promote, or inhibit cancers?. J Clin Epidemiol 48 (1995) 1407-1412
9. Dalton S.O., Johansen C., Mellemkjaer L., Sorensen H.T., McLaughlin J.K., Olsen J., et al. Antidepressant medications and risk for cancer. Epidemiology 11 (2000) 171-176
10. Coogan P.F., Palmer J.R., Strom B.L., and Rosenberg L. Use of selective serotonin reuptake inhibitors and the risk of breast cancer. Am J Epidemiol 162 (2005) 835-838
11. Lawlor D.A., Jüni P., Ebrahim S., and Egger M.J. Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer. Clin Epidemiol 56 (2003) 155-163
12. Alfonso J., Frick L.R., Silberman D.M., Palumbo M.L., Genaro A.M., and Frasch A.C. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol Psychiatry 59 (2006) 244-251
13. Mongini C., Ruybal P., Gravisaco M.J., Croci M., Sánchez Lockhart M., Fabris V., et al. Characterization of the immunophenotype and the metastatic properties of a murine T-lymphoma cell line. Unexpected expression of cytoplasmatic CD4. In Vitro Cell Dev Biol Anim 37 (2001) 499-504
14. Brandes L.J., Arron R.J., Bogdanovic R.P., Tong J., Zaborniak C.L., Hogg G.R., et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 52 (1992) 3796-3800
15. Arimochi H., and Morita K. Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. Eur J Pharmacol 541 (2006) 17-23
16. Abdul M., Logothetis C.J., and Hoosein N.M. Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines. J Urol 154 (1995) 247-250
17. Levkovitz Y., Gil-Ad I., Zeldich E., Dayag M., and Weizman A. Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 27 (2005) 29-42
18. Spanova A., Kovaru H., Lisa V., Lukasova E., and Rittich B. Estimation of apoptosis in C6 glioma cells treated with antidepressants. Physiol Res 46 (1997) 161-164
19. Xia Z., Bergstrand A., DePierre J.W., and Nassberger L. The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol 13 (1999) 338-347
20. Serafeim A., Holder M.J., Grafton G., Chamba A., Drayson M.T., Luong Q.T., et al. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood 101 (2003) 3212-3219
21. Volpe D.A., Ellison C.D., Parchment R.E., Grieshaber C.K., and Faustino P.J. Effects of amitriptyline and fluoxetine upon the in vitro proliferation of tumor cell lines. J Exp Ther Oncol 3 (2003) 169-184
22. Serafeim A., Grafton G., Chamba A., Gregory C.D., Blakely R.D., Bowery N.G., et al. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 99 (2002) 2545-2553
23. + helper T-cells in antitumor immunity. Int J Hematol 77 (2003) 435-438
24. Nozoe T., Maehara Y., and Sugimachi K. Preoperative sorting of circulating T lymphocytes in patients with esophageal squamous cell carcinoma: its prognostic significance. World J Gastroenterol 11 (2005) 6689-6693
25. Vonderheid E.C., Pena J., and Nowell P. Sezary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging. Leuk Lymphoma 47 (2006) 1841-1856
26. Dredge K., Marriott J.B., Todryk S.M., and Dalgleish A.G. Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy. Cancer Immunol Immunother 51 (2002) 521-531
27. Dunn G.P., Koebel C.M., and Schreiber R.D. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6 (2006) 836-848
28. Ibe S., Qin Z., Schuler T., Preiss S., and Blankenstein T. Tumor rejection by disturbing tumor stroma cell interactions. J Exp Med 194 (2001) 1549-1559
29. Smyth M.J., Cretney E., Takeda K., Wiltrout R.H., Sedger L.M., Kayagaki N., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 193 (2001) 661-670
30. Pennica D., Nedwin G.E., Hayflick J.S., Seeburg P.H., Derynck R., Palladino M.A., et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312 (1984) 724-729
31. Lejeune F.J., Lienard D., Matter M., and Ruegg C. Efficiency of recombinant human TNF in human cancer therapy. Cancer Immun 6 (2006) 6
32. Larmonier N., Cathelin D., Larmonier C., Nicolas A., Merino D., Janikashvili N., et al. The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Exp Cell Res 313 (2007) 2345-2355
33. Rook A.H., Wood G.S., Yoo E.K., Elenitsas R., Kao D.M., Sherman M.L., et al. Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses. Blood 94 (1999) 902-908
34. Krawczyk C.M., Verstovsek S., Ujházy P., Maccubbin D., and Ehrke M.J. Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 mice. Cancer Immunol Immunother 40 (1995) 347-357
35. Pacher P., Ungvari Z., Kecskeméti V., Friedmann T., and Furst S. Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle. Can J Physiol Pharmacol 79 (2001) 580-584
36. Brust P., Friedrich A., Krizbai I.A., Bergmann R., Roux F., Ganapathy V., et al. Functional expression of the serotonin transporter in immortalized rat brain microvessel endothelial cells. J Neurochem 74 (2000) 1241-1248
37. Belowski D., Kowalski J., Madej A., and Herman Z.S. Influence of antidepressant drugs on macrophage cytotoxic activity in rats. Pol J Pharmacol 56 (2004) 837-842
38. Mossner R., and Lesch K.P. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 12 (1998) 249-271
39. Barkan T., Gurwitz D., Levy G., Weizman A., and Rehavi M. Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes. Eur Neuropsychopharmacol 14 (2004) 237-243
40. Marazziti D., Rossi A., Giannaccini G., Baroni S., Lucacchini A., and Cassano G.B. Presence and characterization of the serotonin transporter in human resting lymphocytes. Neuropsychopharmacology 19 (1998) 154-159
41. Stefulj J., Jernej B., Cicin-Sain L., Rinner I., and Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun 14 (2000) 219-224
42. Yang G.B., Qiu C.L., Zhao H., Liu Q., and Shao Y. Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques. J Neuroimmunol 178 (2006) 24-29
43. Diamond M., Kelly J.P., and Connor T.J. Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. Eur Neuropsychopharmacol 16 (2006) 481-490
44. Taler M., Gil-Ad I., Lomnitski L., Korov I., Baharav E., Bar M., et al. Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol 17 (2007) 774-780